Cytokinetics reported $-1.5 in EPS Earnings Per Share for its fiscal quarter ending in June of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2025 -1.56 -2.55 Oct/29
FY2026Q2 Jun/2026 -1.50 -1.64 -1.12 Aug/06
FY2026Q1 Mar/2026 -1.67 -1.65 -1.36 May/05
FY2025Q4 Dec/2025 -1.50 -1.56 -1.26 Feb/24
FY2025Q3 Sep/2025 -2.55 -1.57 -1.36 Nov/05




Eps Change Date
Acadia Pharmaceuticals USD 0.18 0.16 Jun/2026
Amgen USD 6.29 1.14 Jun/2026
Arca Biopharma USD -0.58 0.04 Mar/2026
Bayer EUR 0.95 1.76 Jun/2026
Biogen USD 3.6 0.03 Jun/2026
Brainstorm Cell Therapeutics USD -0.19 0 Mar/2026
Bristol-Myers Squibb USD 2.04 0.46 Jun/2026
Capricor Therapeutics USD -0.62 0.08 Dec/2025
Cytokinetics USD -1.5 0.17 Jun/2026
Eisai JPY 64.71 76.24 Jun/2026
Eli Lilly USD 8.38 0.17 Jun/2026
Exelixis USD 0.91 0.04 Jun/2026
Geron USD -0.02 0.01 Jun/2026
Halozyme Therapeutics USD 2.28 0.68 Jun/2026
Ionis Pharmaceuticals USD -0.69 0.13 Jun/2026
Ligand Pharmaceuticals USD 2.37 0.74 Jun/2026
Merck USD -0.13 1.15 Jun/2026
Novartis USD 2.41 0.42 Jun/2026
Pfizer USD 0.77 0.02 Jun/2026
Regeneron Pharmaceuticals USD 14.29 4.82 Jun/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Sanofi EUR 2.09 0.21 Jun/2026